# Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

> **NCT00639938** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 722 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** HIV immune globulin solution

## Key facts

- **NCT ID:** NCT00639938
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 722 (ACTUAL)
- **Last updated:** 2008-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639938, "Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00639938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*